Literature DB >> 9373111

Indocyanine green angiography of multifocal choroiditis.

J S Slakter1, A Giovannini, L A Yannuzzi, B Scassellati-Sforzolini, D R Guyer, J A Sorenson, R F Spaide, D Orlock.   

Abstract

PURPOSE: The purpose of the study is to determine indocyanine green (ICG) angiographic characteristics of patients with multifocal choroiditis (MC) and to identify features that may assist in the differentiation of MC from other ocular inflammatory diseases.
METHODS: After complete ophthalmologic examination, fluorescein angiography and ICG angiography were performed in a series of 14 patients with MC. The ICG findings were then correlated with the clinical and fluorescein angiographic appearance of these patients to determine specific characteristics and distinguishing features of the entity. These findings then were compared with those of angiographic patterns observed in patients with ocular histoplasmosis syndrome to determine whether differentiating features could be identified.
RESULTS: Fourteen (50%) of the 28 eyes were found to have large hypofluorescent spots in the posterior pole on ICG angiography, which, in most cases, did not correspond to clinically or fluorescein angiographically detectable lesions. Seventeen (61%) had smaller hypofluorescent lesions (approximately 50 pm in size) in the posterior pole on the ICG study. In seven eyes exhibiting enlarged blind spots on visual field testing, ICG angiography showed confluent hypofluorescence surrounding the optic nerve. The ICG angiogram was found useful in evaluating the natural course in two patients with MC as well as a response to oral prednisone therapy in four others. The ICG angiographic findings differed from those seen in patients with ocular histoplasmosis.
CONCLUSIONS: Indocyanine green angiography can provide information that is not detectable by clinical or fluorescein angiographic examination in patients with MC. This information may prove useful in differentiating this condition from the ocular histoplasmosis syndrome, provide a better understanding of the natural course and progression of the disease, and provide a potential adjunct in the clinical evaluation of patients undergoing therapeutic regimens for active inflammatory lesions.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9373111     DOI: 10.1016/s0161-6420(97)30022-0

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  14 in total

Review 1.  [Choroiditis].

Authors:  S Thurau; G Wildner
Journal:  Ophthalmologe       Date:  2010-01       Impact factor: 1.059

2.  [Punctate inner choroidopathy - Improvement in vision after anti-VEGF and photodynamic therapy. An 18-month follow-up control].

Authors:  S Weiss; R Winter; M W Meyer
Journal:  Ophthalmologe       Date:  2012-02       Impact factor: 1.059

3.  Age-related scattered hypofluorescent spots on late-phase indocyanine green angiograms.

Authors:  K Shiraki; M Moriwaki; T Kohno; N Yanagihara; T Miki
Journal:  Int Ophthalmol       Date:  1999       Impact factor: 2.031

4.  Idiopathic multifocal choroiditis/punctate inner choroidopathy with acute photoreceptor loss or dysfunction out of proportion to clinically visible lesions.

Authors:  Marion R Munk; Jesse J Jung; Kristin Biggee; William R Tucker; H Nida Sen; Ursula Schmidt-Erfurth; Amani A Fawzi; Lee M Jampol
Journal:  Retina       Date:  2015-02       Impact factor: 4.256

5.  Inflammatory choroidal neovascularization.

Authors:  Piergiorgi Neri; Marta Lettieri; Cinzia Fortuna; Mara Manoni; Alfonso Giovannini
Journal:  Middle East Afr J Ophthalmol       Date:  2009-10

6.  Fluorescein and indocyanine green angiography for uveitis.

Authors:  Carl P Herbort
Journal:  Middle East Afr J Ophthalmol       Date:  2009-10

7.  Scoring of dual fluorescein and ICG inflammatory angiographic signs for the grading of posterior segment inflammation (dual fluorescein and ICG angiographic scoring system for uveitis).

Authors:  Ilknur Tugal-Tutkun; Carl P Herbort; Moncef Khairallah
Journal:  Int Ophthalmol       Date:  2008-09-16       Impact factor: 2.031

8.  Successful treatment of an overlapping choriocapillaritis between multifocal choroiditis and acute zonal occult outer retinopathy (AZOOR) with adalimumab (Humira™).

Authors:  Piergiorgio Neri; Federico Ricci; Alfonso Giovannini; Ilir Arapi; Cecilia De Felici; Andrea Cusumano; Cesare Mariotti
Journal:  Int Ophthalmol       Date:  2013-06-14       Impact factor: 2.031

9.  Myopia and inflammation.

Authors:  Carl P Herbort; Marina Papadia; Piergiorgio Neri
Journal:  J Ophthalmic Vis Res       Date:  2011-10

Review 10.  Classification of Non-Infectious and/or Immune Mediated Choroiditis: A Brief Overview of the Essentials.

Authors:  Carl P Herbort; Alessandro Mantovani; Ilknur Tugal-Tutkun; Ioannis Papasavvas
Journal:  Diagnostics (Basel)       Date:  2021-05-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.